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Background: Gait analysis is increasingly being used to characterise dysfunction of the lower limb and foot in people
with inflammatory arthritis (IA). The aim of the systematic review was to evaluate the spatiotemporal, foot and ankle
kinematic, kinetic, peak plantar pressure and muscle activity parameters between patients with inflammatory arthritis
and healthy controls.
Methods: An electronic literature search was performed on Medline, CINAHL, SportsDiscus and The Cochrane Library.
Methodological quality was assessed using a modified Quality Index. Effect sizes with 95 % confidence intervals (CI)
were calculated as the standardised mean difference (SMD). Meta-analysis was conducted if studies were homogenous.
Results: Thirty six studies with quality ranging from high to low met the inclusion criteria. The majority of studies
reported gait parameters in Rheumatoid arthritis (RA). The gait pattern in RA was characterised by decreased walking
speed (SMD 95 % CI −1.57, −2.25 to −0.89), decreased cadence (SMD −0.97, −1.49 to −0.45), decreased stride length
(SMD −1.66, −1.84 to −1.49), decreased ankle power (SMD −1.36, −1.70 to −1.02), increased double limb support time
(SMD 1.03, 0.84 to 1.22), and peak plantar pressures at the forefoot (SMD 1.11, 0.76 to 1.45). Walking velocity was reduced
in psoriatic arthritis and gout with no differences in ankylosing spondylitis. No studies have been conducted in polymyalgia
rheumatica, systemic sclerosis or systemic lupus erythematosus.
Conclusions: The review identified the majority of studies reporting gait adaptations in RA, but limited evidence relating to
other IA conditions. Poor data reporting, small sample sizes and heterogeneity across IA conditions limit the interpretation
of the findings. Future studies may consider a standardised analytical approach to gait analysis that will provide clinicians
and researchers with objective evidence of foot function in people with IA.
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The term ‘inflammatory arthritis’ (IA) has been used to
describe a number of inflammatory joint diseases includ-
ing: rheumatoid arthritis (RA), ankylosing spondylitis
(AS), psoriatic arthritis (PsA) and gout [1]. RA is a
chronic progressive autoimmune disease characterized
by joint swelling, joint tenderness and destruction of
synovial joints [2]. SpA encompasses a heterogeneous
group of inflammatory arthritic conditions, characterised
by vertebral involvement, peripheral oligoarthritis or* Correspondence: matthew.carroll@aut.ac.nz
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creativecommons.org/publicdomain/zero/1.0/polyarthritis, enthesitis, AS, PsA and undifferentiated
spondyloenthesoarthritis [3, 4]. Gout is a common form
of inflammatory arthritis caused by the deposition of
monosodium urate crystals within joints and other soft
tissue associated with hyperuricaemia [5]. IA causes
lower limb and foot pain and impairment, functional
disability, reduced mobility, joint deformity and altered
gait strategy [6–10]. Foot pain is considered an import-
ant factor in the development of antalgic gait in IA, spe-
cifically in RA and gout [6, 11, 12]. In RA, foot pain is
derived from structural and functional alterations associ-
ated with inflammatory and structural change [6, 13].
With the development of an antalgic gait, adaptations
occur based upon a pain avoidance strategy. Previousticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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include: a decrease in walking velocity and subsequent
alterations to velocity related spatiotemporal parame-
ters including, reduced cadence, increased double limb
support time and decreased step length [14–18].
Changes to kinematic parameters including, reduced
sagittal plane ankle ROM and increased peak rearfoot
eversion have also been reported [7, 14, 17, 18]. Fur-
thermore, previous studies have reported alteration to
kinetic parameters including, reduced peak ankle plan-
tarflexor power associated with reduced walking vel-
ocity, reduced ankle joint ROM, reduced ankle joint
angular velocity, reduced ankle plantarflexor moments
and decreased strength of the ankle plantarflexor mus-
cles [16, 17, 19]. An increase in peak forefoot plantar
pressure parameters has also been reported in RA [16].
Gait analysis provides information about spatial-
temporal parameters, kinetics, kinematics and muscle
activity to further delineate the relationship between
joint disease, joint impairments and compensatory gait
strategies adopted to overcome painful and disabling
deformities [15, 20]. Gait analysis has been reported as
a useful clinical tool to quantify foot function in both
early and established RA [7, 8, 14, 15]. However, less
common IA conditions, such as AS, PsA, gout, poly-
myalgia rheumatica, systemic sclerosis and systemic
lupus erythematosus, also have various consequencesFig. 1 Flow of information through different stages of systematic review. RAfor the lower limb such as changes in foot function,
and extra articular complications involving the skin and
vascular integrity [9, 10, 12, 21–24]. A recent system-
atic review of studies investigating walking abnormal-
ities associated with RA, Baan [25] identified changes
in gait such as a slower walking, longer double support
time, and avoidance of extreme positions. These
changes were in relation to the frequently found static
features in RA, for instance, hallux valgus, pes plano-
valgus and rearfoot abnormalities. However, Baan [25]
only reported gait parameters in RA and did not con-
sider other IA conditions. However, recently there has
been an interest in evaluating gait patterns in other IA
conditions that includes gout [12], PsA [21] and AS
[10]. No previous systematic review has conducted
meta-analysis of gait parameters in IA compared to
healthy control population. The aim of the systematic
review was to evaluate spatiotemporal, foot and ankle
kinematic, kinetic, peak plantar pressure and muscle
activity parameters in people with IA and healthy
controls.
Methods
Identification of studies
Four electronic databases were searched (Medline,
CINAHL, SportsDiscus and The Cochrane Library).
The search was completed in March 2015. The search= rheumatoid arthritis, AS = ankylosing spondylitis, PsA = psoriatic arthritis
Table 1 Characteristics of included studies
Author IA Case demographics Control demographics Gait parameters investigated
Number Gender
(F:M)
Age Number Gender Age ST KIM KIN PP EMG
mean (SD) (F:M) mean (SD)
Turner [7] RA 23 14:9 49.4 (10.5) 23 14:9 49.5 (13.6) ■ ■ ■
Woodburn [8] RA 11 9:2 59.6 (12.0) 5 NR NR ■ ■
O’Connell [11] RA 10 8:2 54.0 7 5:2 34.0a ■ ■ ■ ■
Woodburn [13] RA 50 34:16 54.0 (11.8) 45 29:16 51.8 (12.4) ■
Turner [14] RA 12 (FF) 9:3 7.9 (9.3) 53 33:20 55.2 (11.7) ■ ■ ■
10 (RF) 8:2 53.8 (13.2)
6 (COMB) 4:2 64.7 (6.9)
Turner [15] RA 74 58:16 56.4 (12.0) 53 33:20 55.2 (11.7) ■ ■ ■ ■
Turner [16] RA 12 12:0 46.0a 12 12:0 47.0a ■ ■ ■ ■
Weiss [17] RA 50 43:7 55.0 (14.0) 37 22:15 51.0 (14.0) ■ ■ ■
Khazzam [18] RA 22 20:2 54.0a 25 12:13 41.0a ■ ■
Barn [19] RA 10 6:4 50.0 (9.0) 5 3:2 47.0 (6.0) ■ ■ ■
Woodburn [34] RA 10 NR 52.3a 10 NR 27.9a ■
Bowen [36] RA 114 93:21 59.6 (12.0) 49 37:12 33.2a ■
Dubbeldam [37] RA 21 17:4 46.6 (12.8) 14 11:3 41.6 (8.5) ■ ■
Yavuz [38] RA 9 8:1 53.2 (12.3) 14 9:5 53.6 (18.7) ■
Rome [39] RA 19 15:4 56.1 (11.1) 21 12:9 51.0 (8.9) ■
Eppeland [40] RA 17 7:10 51.1 (6.2) 20 8:12 50.4 (5.3) ■
Schmiegel [41] RA 21 NR 57.1 (10.2) 16 NR 50.8 (9.4) ■
Schmiegel [42] RA 112 NR 55.0 (11.0) 20 NR 53.2 (12.3) ■
Laroche [43] RA 9 6:3 60.0 (7.0) 9 7:2 60.0 (7.0) ■ ■
Laroche [44] RA 9 6:3 60.6 (6.8) 7 5:2 58.5 (7.4) ■ ■ ■
Semple [45] RA 74 58:16 54.6 (12.0) 53 33:20 55.2 (11.7) ■ ■
Rosenbaum [46] RA 25 23:2 55.0 (9.9) 21 20:1 50.8 (9.3) ■
Tuna [47] RA 50 38:12 50.0 (9.0) 50 39:11 49.8 (7.6) ■
Otter [48] RA 25 21:4 45.3 (12.7) 25 22:3 48.0 (8.6) ■
Woodburn [49] RA 102 76:26 63.5a 42 31:11 61.0a ■
Siegel [50] RA 4 3:1 56.5 (7.2) 2 2:0 28.0 (11.0) ■ ■
Fransen [51] RA 113 76:37 60.0 (5.5) 102 67:35 58.7 (5.3) ■
Isacson [52] RA 17 17:0 40.0 (5.0) 11 11:0 29.0 (7.0) ■ ■
Minns [53] RA 124 104:20 56.6a 67 32:35 50.2 (10.2) ■ ■
Simkin [54] RA 18 11:7 58.0a 20 10:10 51.0a ■ ■
Stauffer [55] RA 30 18:12 NR 29 15:14 NR ■ ■
Del Din [10] AS 12 4:8 49.4 (10.5) 12 4:8 55.75 (3.2) ■ ■ ■
Mangone [56] AS 17 2:15 47.0 (21.9) 10 1:9 38.7 (14.5) ■ ■
Zebouni [57] AS 12 4:8 46.5a 11 NR 39.5a ■ ■
Woodburn [21] PsA 42 25:17 45.3 (12.7) 29 18:11 40.0 (10.5) ■ ■ ■
Rome [12] GT 25 6:19 61.2 (11.7) 25 6:19 57.3 (12.2) ■ ■
SD standard deviation, NR not reported, IA inflammatory arthritis, RA rheumatoid arthritis, GT gout, AS ankylosing spondylitis, PsA psoriatic arthritis, ST
spatiotemporal, KIM kinematic, KIN kinetic, PP plantar pressure, EMG electromyography, FF group severe forefoot deformity group, RF group severe rearfoot
deformity group, COMB group severe fore- and rearfoot deformity group
a SD not reported
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Table 2 Modified quality index
Publication Reporting External validity Internal validity bias Internal validity confounding
1. Hypothesis
clearly
described?
2. Main
outcomes
clearly
described?
3. Characteristics
of the patients
included clearly
described?
5. Distribution
of principle
confounder
of each group
clearly
described?
6. Main
findings
clearly
described?
7. Estimates
of random
variability
provided
for the main
outcomes?
10. Actual
probability
values
reported
for main
outcomes?
11. Were the
subjects asked
to participate
representative
of the entire
population?
12. Were the
subjects who
were prepared
to participate
representative
of the entire
population?
16. Was it
clear if the
results
were based
on “data
dredging”
18. Were the
statistical tests
appropriate?
20. Were
the main
outcome
measures
valid and
reliable?
21. Were all
patients
and controls
recruited from
the same
population?
22. Were all
patients
and controls
recruited
over the
same time
period?
Quality
Index
score
total (%)
Turner [7] 1 1 1 1 1 1 0 0 0 1 1 0 0 0 8 (53)
Woodburn [8] 1 1 0 0 0 1 0 0 0 1 0 1 0 0 5 (33)
Del Din [10] 1 1 1 2 1 1 1 1 0 1 1 1 1 0 13 (87)
O’Connell [11] 1 1 0 0 1 0 0 0 0 1 0 0 0 0 4 (27)
Rome [12] 1 1 1 1 1 1 1 0 0 1 1 1 1 0 11 (73)
Woodburn [13] 1 1 1 2 1 1 1 0 0 1 1 1 0 0 11 (73)
Turner [14] 1 1 1 2 1 1 1 0 0 1 1 1 1 0 12 (80)
Turner [15] 1 1 1 2 1 1 0 0 0 1 1 1 0 0 10 (67)
Turner [16] 1 1 1 1 1 0 0 1 1 1 0 1 1 0 10 (67)
Weiss [17] 1 1 0 1 1 1 1 0 0 1 1 1 1 0 10 (67)
Khazzam [18] 1 1 0 0 1 1 1 1 0 1 1 1 1 1 11 (73)
Barn [19] 1 1 1 2 1 1 1 0 0 1 1 0 0 1 11 (73)
Woodburn [21] 1 1 1 2 1 1 1 0 0 1 1 0 0 0 10 (67)
Woodburn [34] 1 1 1 2 1 0 0 1 0 1 1 1 1 0 11 (73)
Bowen [36] 1 1 1 2 1 1 1 0 0 1 1 1 0 1 12 (80)
Dubbeldam [37] 1 1 1 1 0 1 1 0 0 1 1 1 0 0 9 (60)
Yavuz [38] 1 1 0 0 0 1 0 0 0 1 1 0 0 0 5 (33)
Rome [39] 1 1 1 1 1 1 1 0 0 1 1 0 0 0 9 (60)
Eppeland [40] 1 1 1 2 1 1 1 1 1 1 1 0 1 0 13 (87)
Schmiegel [41] 1 1 1 2 1 1 0 0 0 1 1 1 0 0 10 (67)
Schmiegel [42] 1 1 1 2 1 1 0 1 1 1 1 0 1 0 12 (80)
Laroche [43] 1 1 1 0 1 0 1 0 0 1 0 0 0 0 6 (40)
Laroche [44] 1 1 1 0 1 1 1 1 1 1 1 1 0 0 11 (73)
Semple [45] 1 1 1 0 1 1 1 1 1 1 1 1 0 0 11 (73)
Rosenbaum [46] 1 1 1 1 1 1 1 0 0 1 1 1 0 0 10 (67)
Tuna [47] 1 1 1 1 1 1 0 0 0 1 1 0 0 0 8 (53)
Otter [48] 1 0 1 1 0 1 1 0 0 1 1 0 1 0 8 (53)
Woodburn [49] 1 1 1 2 1 1 1 0 0 1 1 1 0 0 11 (73)
Siegel [50] 1 1 0 0 0 0 0 0 0 1 0 0 0 0 3 (20)
Fransen [51] 1 1 1 2 1 1 1 0 1 1 1 0 1 0 12 (80)
Isacson [52] 1 0 1 0 1 0 0 0 0 1 1 0 1 0 6 (40)
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Table 2 Modified quality index (Continued)
Minns [53] 0 0 1 1 1 0 0 0 0 1 0 0 0 0 4 (27)
Simkin [54] 1 1 0 0 0 0 0 0 0 1 0 0 0 0 3 (20)
Stauffer [55] 1 1 1 1 1 0 0 0 0 1 0 1 0 1 8 (53)
Mangone [56] 1 1 1 0 0 1 1 0 0 1 1 0 0 0 7 (47)
Zebouni [57] 1 1 0 0 0 0 0 0 0 1 1 0 0 0 4 (27)
Median 10 (67)
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Fig. 2 Forest plot of studies reporting walking velocity. AS, ankylosing spondylitis; RA, rheumatoid arthritis; CI, confidence interval
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location; the type of gait analysis and IA condition
(Additional file 1: Table S1). An initial review was
undertaken of all titles and abstracts. All articles con-
sidered appropriate were read in full to establish if they
met the eligibility criteria.
Inclusion and exclusion criteria
Studies were included if they: reported people with IA
that included; RA, AS, PsA, gout, polymyalgia rheu-
matica, systemic sclerosis and systemic lupus erythe-
matosus; if they assessed adults aged >18 years old; if
they reported spatiotemporal, kinematic, kinetic, peak
plantar pressure or muscle activity data during gait; if
they were articles that included a healthy group as
means of comparison. Only articles published in EnglishFig. 3 Forest plot of studies reporting cadence. RA, rheumatoid arthritis; CIwere included. Surgical and pharmacological intervention
studies were excluded. No limitation was placed on the
date of the publication with databases screened up to
March 2015.Data extraction
All titles and abstracts identified through database
searches were downloaded into Endnote X4 (Thomson,
Reuters, Carlsbad, CA). Each title and abstract was
evaluated for potential inclusion by two independent
reviewers (MC, KR). If there was insufficient informa-
tion contained in the title to determine suitability the
full text was obtained. Any discrepancies between the
two reviewers (MC, KR) were resolved at a consensus
meeting., confidence interval
Fig. 4 Forest plot of studies reporting stride length. AS, ankylosing spondylitis; RA, rheumatoid arthritis; CI, confidence interval
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The quality of studies was evaluated independently by
two reviewers (MC and KR), who were blinded to au-
thor and publication details. Study quality was rated
using a modified version of the Quality Index (QI) tool
originally described by Downs and Black [26]. The QI
tool consists of 27 items which allow for the assess-
ment of internal and external validity, reporting of
bias and power. The tool was modified to exclude thir-
teen questions that were not relevant to the articles
assessed in this review, resulting in the retention of 14
questions. The scoring system grades each of the 14
questions either a (0 = no/unable to determine, or 1 =
yes) with the exception of question five (0 = no, 1 =
partially, 2 = yes). The summed score for each study
was calculated, the maximum achievable being 15. No
cut off scores have been described to categorise study
quality for the Downs and Black quality Index [27]. InFig. 5 Forest plot of studies reporting double support time. RA, rheumatoithe absence of validated cut off scores and following
review of past articles that have applied the Downs
and Black criteria the follow cut off values were ap-
plied: ≥ 12 was considered high quality, ≥ 7 but < 12 as
moderate quality, and < 6 as poor quality [27, 28].
Data analysis and synthesis
Relevant gait parameters and information regarding
overall study design, subject characteristics and gait
analysis parameters were extracted from each paper by
one author (MC) from those studies meeting the in-
clusion criteria. Data was tabulated according to the
specific IA condition and gait parameters.
The clinical and methodological diversity among
the studies was assessed to determine the appropri-
ateness of data pooling for meta-analysis. Factors
considered important for comparison included: mean
age, sex distribution, case and comparison group size,d arthritis; CI, confidence interval
Fig. 6 Forest plot of studies reporting ankle range of motion. RA, rheumatoid arthritis; CI, confidence interval
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Two authors (MC and PP) reviewed the included
studies and reached consensus on the appropriateness
of conducting meta-analysis. Heterogeneity was con-
sidered low if the I2 value was ≤ 25 %, moderate if the
value was > 25 % and ≤ 50 %, high if > 50 % and ≤ 75 %
and very high if greater than 75 % [29]. A fixed-effect
model was applied where the I2 statistic was less than 50 %
and the Chi2 test indicated a non-significant degree of het-
erogeneity (P > 0.1). The random-effect model was used
where the I2 statistic was greater than 50 % and the
Chi2 test indicated statistically significant heterogeneity
(P < 0.1) [30].
Where data was available from each paper a stan-
dardised mean difference (SMD) (Hedges’s g) and
95 % confidence interval (CI) were calculated [31].
This was calculated as the difference between cases
and control group means divided by the pooled SD.
Interpretation of SMDs was based on previous effect
size (ES) guidelines: small effect ≥ 0.2, medium ef-
fect ≥ 0.5, large effect ≥ 0.8 [32]. Effect sizes were con-
sidered statistically significant if the 95 % CI did not
contain zero for the SMD. All data were analysed
using the Comprehensive Meta-analysis, version 2
[33]. When mean and SD was not reported, the me-
dian and range were reported. Studies that met the
inclusion criteria but did not report SD, or where theFig. 7 Forest plot of studies reporting ankle power. RA, rheumatoid arthritiSD could not be obtained were excluded from meta-
analysis (Additional file 2: Table S2).
Results
Selection and characteristics of studies
A total of 3134 citations were identified for screening
with 36 articles being included for further analysis
(Fig. 1). Thirty-one studies evaluated gait parameters in
RA [7, 8, 11, 13–18, 34–55], three in AS [10, 56, 57]
one in PsA [21] and one in gout [12]. Twenty-four
studies examined spatiotemporal gait parameters, with
19 in RA, two in AS, one PsA and gout (Additional file
3: Table S3). Twenty-one studies assessed kinematic pa-
rameters, with 17 in RA, three AS and one in PsA
(Additional file 4: Table S4). Ten studies examined kin-
etic parameters with eight in RA, one AS and one in
PsA (Additional file 5: Table S5). Sixteen studies evalu-
ated plantar pressure parameters, with 15 in RA and
one in gout (Additional file 6: Table S6). Three studies
assessed all gait parameters (spatiotemporal, kine-
matic, kinetic and plantar pressures) in the popula-
tion of interest [11, 14, 15]. No studies reported gait
characteristics in polymyalgia rheumatica, systemic
sclerosis and systemic lupus erythematosus. The total
number of participants was 2275; 1321 with IA and
954 controls. IA participants included 863 females
and 312 males. The mean (SD) age of IA cases ands; CI, confidence interval
Fig. 8 Forest plot of studies reporting forefoot peak plantar pressure. RA, rheumatoid arthritis; CI, confidence interval
Carroll et al. BMC Musculoskeletal Disorders  (2015) 16:134 Page 9 of 13controls was 52.6 (9.3) and 47.8 (9.2) years, respect-
ively (Table 1).Methodological quality of studies
Two reviewers (MC & KR) individually scored a total
of 504 items and agreed on 480 items (95 %) with an
inter-rater agreement of ƙ = 0.90 (p < 0.001). Six of the
36 articles were of high quality (quality score ≥ 12).
The median (%) quality score of all articles was 10 (67 %),
ranging between 20–87 % (Table 2). There was limited in-
formation on the methods of study recruitment across
the majority of studies making it difficult to assess the
generalisability of study results. The majority of studies
investigating kinematic and kinetic parameters also re-
ported small sample sizes.Spatiotemporal gait parameters
Fifteen RA [7, 14–18, 37, 39, 40, 44, 45, 51–54], one
PsA [21] and one gout study [12] reported significant
decreases in walking velocity. No significant differ-
ences in walking velocity were reported for AS [10,
56]. Overall pooled data (SMD, 95 % CI) (Fig. 2) for
walking velocity, demonstrated a significant decreased
large effect size for RA (SMD −1.55, −2.27 to −0.83)
and a non-significant decrease for AS (SMD −0.19,
−0.73 to 0.36).Fig. 9 Forest plot of studies reporting rearfoot peak plantar pressure. RA, rhFive RA studies [7, 17, 37, 39, 53] and one gout (52)
reported significant decreases in cadence. Cadence was
not significantly decreased in AS [57]. Overall, pooled
data for cadence in RA (Fig. 3) showed a decreased but
significant large effect size (SMD −0.97, −1.49 to
−0.45). Nine RA studies [7, 17, 18, 37, 44, 51–54], one
AS [57] and one gout [12] reported significant de-
creases in stride length. Pooled data for stride length in
RA (SMD −1.66, −1.84 to −1.49) and AS (SMD −0.62,
−1.08 to −0.27) were significantly decreased with a
large effect size (Fig. 4). Eight RA studies [7, 14–17,
37, 39, 51] and one gout study [12] reported significant
increases in double support. Pooled data for double
support in RA showed (Fig. 5) a significantly increased
large effect size (SMD 1.01, 0.66 to 1.36).
Kinematic and kinetic gait parameters
Five RA studies reported on the total ankle range of
motion [7, 8, 11, 13, 52]. Three studies reported no sig-
nificant differences [8, 13, 52], with one study report-
ing a significant increase [7] and one study reporting a
significant decrease in the total ankle range of motion
[11]. Results of the meta-analysis (Fig. 6) demonstrated
that the overall effect size for total ankle range of mo-
tion was non-significant (SMD −0.64, −1.66 to 0.39).
Ankle power was reported in three RA [15, 16, 35] and
one PsA study [21]. All four studies reported significanteumatoid arthritis; CI, confidence interval
Fig. 10 Forest plot of studies reporting midfoot peak plantar pressure. RA, rheumatoid arthritis; CI, confidence interval
Carroll et al. BMC Musculoskeletal Disorders  (2015) 16:134 Page 10 of 13reductions in ankle power. The overall effect size for
ankle power in RA (Fig. 7) was significantly large (SMD
−1.36, −1.70 to −1.02).
Peak plantar pressure gait parameters
Three RA studies [14, 16, 47, 48] reported signifi-
cantly higher forefoot peak plantar pressures in RA.
Results from the meta-analysis (Fig. 8) showed that
the overall effect size for peak plantar pressure to
the forefoot was significantly large (SMD 1.09, 0.51
to 1.67). Pooled results in the RA studies demon-
strated no significant differences in peak plantar pres-
sure for the rearfoot (Fig. 9), midfoot (Fig. 10), first
metatarsal (Fig. 11), 2nd metatarsal (Fig. 12) and the
3–5th metatarsal heads (Fig. 13). Hallux peak plantar
pressure (Fig. 14) was reported to be significantly
lower in gout [12].
Muscle activity
One RA study investigated muscle activity of the tibi-
alis posterior muscle and reported increased muscle
activity during the single support phase of gait [35].
Discussion
This systematic review highlights significant differ-
ences in gait variables between people with IA andFig. 11 Forest plot of studies reporting 1st metatarsophalangeal peak plantcontrols. The review found the majority of studies re-
port on RA with a limited number of studies on other
IA conditions. The review found similar findings to
previous studies, that people with RA adopt an antal-
gic gait resulting from a pain avoidance pattern that
contributes to a decrease in walking velocity, cadence,
increased double limb support time, and decreased
ankle power with increased peak plantar pressures to
the forefoot [11, 15, 17, 18]. Antalgic gait was also
found in gout and AS suggesting that adaptation may
occur due to the disease or a compensatory mechan-
ism to accommodate for localised foot pain and de-
formity [14]. Gait adaptation in PsA may relate to
entheseal foot pathologies and foot pain [9, 58].
Woodburn [21] postulated a stress shielding mechan-
ism may be the driver of gait adaptation with walking
speeds decreased in attempt to lower stress at the
Achilles tendon. The review found a reduction in peak
plantar pressure under the first metatarsal head, sug-
gesting that people with gout may use a pain-
avoidance strategy to reduce the pain associated with
the structural joint damage of the first metatarsopha-
langeal joint.
The chief advantage of three-dimensional (3D) mo-
tion analysis is that dynamic assessments of foot mo-
tion during functional activities, such as walking, can
be performed [59]. Recent advances in motion capturear pressure. RA, rheumatoid arthritis; CI, confidence interval
Fig. 12 Forest plot of studies reporting 2nd metatarsophalangeal peak plantar pressure. RA, rheumatoid arthritis; CI, confidence interval
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the definition of relatively small segments in the foot
[59]. In the last decade there has been an exponential
growth in the use of 3D models to explain gait strat-
egies [60]. The development of detailed foot models is
beginning to quantify the kinematics and kinetics of the
foot, however there are limitations for use in people
with IA. Issues related to soft tissue artefacts and the
validity of skin markers to track underlying skeletal seg-
ments remains problematic. Inaccurate identification of
anatomical landmarks due to the presence of foot de-
formity in IA may affect the estimation, interpretation
and reconstruction of joint axis and ultimately the cal-
culation of joint kinematics and kinetics [61]. The de-
velopment of foot models has also increased the detail
and variety of 3D motion analysis variables used to ex-
plain gait strategies in people with IA. In comparison
to spatiotemporal gait parameters and plantar pressure
variables there appears to be no consensus as to the
most important gait variables that relate to overall
functional status.
This review has some limitations. There was a large
variation in the disease activity, disease duration and
level of deformities across all studies. Many studies
used relatively small samples that were underpowered
and the heterogeneous nature of the IA population
makes interpretation of the data difficult. A number ofFig. 13 Forest plot of studies reporting 3rd to 5th metatarsophalangeal peastudies were included in the review but excluded from
data pooling due to a lack of data reporting of stand-
ard deviations and mean values of gait parameters.
Previous studies have described a wide range of meth-
odologies to acquire and define gait parameters and
this complicates the synthesis of data across different
studies. The review was restricted to case-control
studies and did not consider findings from interven-
tion studies. We only analysed the foot and ankle
characteristics in IA, with no consideration given to
data from the knee, hip and pelvis.
Two key pathways have been postulated to contrib-
ute to the development of foot pain and deformity in
IA: inflammatory and/or mechanical [59]. However,
limited objective evidence exists to comprehensively
examine inflammatory and mechanical markers in the
context of foot pain and deformity across IA condi-
tions. Given the limited data across all IA conditions,
future directions should include analysis of muscle ac-
tivity; this will provide information on the forces pro-
ducing movements and patterns of muscle activation.
Future research is required to understand the com-
bined effects of spatiotemporal, kinematic, kinetic and
plantar pressure impact on foot function. This will
allow for relationships to be investigated across the
differing gait parameters and may further define the
mechanism of gait adaptation with IA conditions.k plantar pressure. RA, rheumatoid arthritis; CI, confidence interval
Fig. 14 Forest plot of studies reporting hallux peak plantar pressure. RA, rheumatoid arthritis; CI, confidence interval
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The advancement of 3D gait analysis has given a
clearer insight into the complex interaction between
the underlying mechanisms of inflammation and
mechanical pathways that influence the development
of foot problems in people with IA. The review identi-
fied 36 gait studies with the majority of studies
reporting gait adaptations in RA, but limited evidence
relating to other IA conditions. Poor data reporting,
small sample sizes and heterogeneity across IA condi-
tions limit the interpretation of the findings. Future
studies should consider a standardised analytical ap-
proach to gait analysis that will enable comparisons
across studies and provide clinicians and researchers
with objective evidence of foot function in people
with IA.
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